Physician profile
Eric M Saunders
NPI 1699730937
$2,270.53
in general payments reported to CMS, 2019-2025
21 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.28 · 2020: $69.43 · 2021: $243 · 2022: $748 · 2023: $294 · 2024: $200 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,153.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $376.14 | 2021-2023 | Cequa |
| Bausch & Lomb Americas INC. | $340.86 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $318.21 | 2022-2025 | Tyrvaya |
| Abbvie INC. | $176.20 | 2022-2025 | |
| Allergan, INC. | $163.75 | 2019-2021 | |
| Alcon Vision LLC | $128.55 | 2021-2025 | Rocklatan, Dailies |
| Tarsus Pharmaceuticals, INC. | $127.33 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $93.45 | 2025 | Idosetr |
| Aerie Pharmaceuticals, INC. | $84.38 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $70.62 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $68.24 | 2019-2023 | |
| Astellas Pharma US INC | $52.83 | 2024 | Izervay |
| Amgen INC. | $51.10 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $38.91 | 2022 | |
| Eyevance Pharmaceuticals LLC | $37.70 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $31.39 | 2021-2022 | |
| Coopervision INC. | $31.33 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.06 | 2019-2020 | |
| Balt USA, LLC | $23.82 | 2025 | Prestige Coil System |
| Ocular Therapeutix, INC. | $13.66 | 2022 | |
| Sight Sciences, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.